| - | Altered expression of cyclic citrullinated peptide in Rheumatoid Arthritis | Hafeza Akter; Min-Jung Kang; Yoo, Young Sook |
| - | Development of a CE-LIF-based PKC assay method and its application to inhibitor's screening | Nguyen Thanh Binh; Hafeza Akter; SEONGYOUNSEO; Min-Jung Kang |
| - | Development of Cholecystokinin and Neurotensin as biomerkers in clinical samples using ELISA | Hafeza Akter; Hyojeong Han; Kwon, Oh-Seung; Jung, Byung Hwa; Won-Sang Park; Min-Jung Kang |
| - | Proteomic approach to discover organ specific biomarkers for cardiac disease | Joyeta Mahmud; Hafeza Akter; Min-Jung Kang |
| - | Specificity of NTR1 as a Therapeutic Target for Gastric Cancer | Hafeza Akter; Yoo, Young Sook; Kwon, Oh-Seung; Min-Jung Kang |
| - | Specificity of NTR1 as a therapeutic target of gastric cancer | Hafeza Akter; Kwon, Oh-Seung; Yoo, Young Sook; Min-Jung Kang |
| - | Substance P and Neuropeptide Y as biomarkers for diagnosis of acute myocardial infarction using quantum dots-labeled immunoassay | Hyojeong Han; Hafeza Akter; Woo Kyoungja; Jung, Byung Hwa; Min-Jung Kang |
| - | Substance P and Neuropeptide Y as Potential Biomarkers for Diagnosis of Acute Myocardial Infarction using ELIA | Hafeza Akter; Hyojeong Han; Kwon, Oh-Seung; Jung, Byung Hwa; Min-Jung Kang |
| - | Substance P and Neuropeptide Y as Potential Biomarkers for Diagnosis of Acute Myocardial Infarction using Enzyme-Linked Immunosorbent Assay | Hyojeong Han; Hafeza Akter; Jung, Byung Hwa; 서홍석; Min-Jung Kang |
